T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

Interleukin-1 (IL-1) is a key molecule involved in inflammation and plays an important role in both healthy and diseased states. In disease, high ...

Occupational pesticide exposure threatens women's health as it leads to an increase in breast cancer risk for young women, ...

Bio-Techne has a market capitalization of $11.65 billion. The Zacks Consensus Estimate for the company’s fiscal 2025 earnings indicates a 5.1% year-over-year increase on a 5.5% revenue improvement. In ...

Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of new designer proteins engineered using advanced Artificial Intelligence (AI) based design ...

Pritzker described the upcoming budget as “challenging” but added that since taking office, he’s addressed a number of fiscal crises in Illinois. “We are doing the best that we can to try ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

To identify this year’s Drugs to Watch 2025 list, Clarivate drew from expertise from over 160 Clarivate analysts covering hundreds of diseases, drugs, and markets and 11 integrated data sets that span ...

Objective Juvenile SLE (jSLE) is an autoimmune disease characterised by the presence of high levels of autoantibodies, predominantly targeting nuclear antigens, resulting in a breakdown of ...

A bill that would have effectively banned the sale of delta-8 and other hemp intoxicants outside of dispensaries is likely ...

A bill that would have effectively banned the sale of delta-8 outside of dispensaries is likely dead after the Illinois House failed to call it for a vote.

Yeilding's entering into employment with the Company in accordance with Nasdaq Marketplace Rule 5635(c)(4). Protagonist Therapeutics is a late-stage development ... is the first targeted oral peptide ...